drugset / Trial / NCT00517582

Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

NCT00517582

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Individuals with heart disease or high blood pressure are often prescribed angiotensin converting enzyme (ACE) inhibitors to treat their disease. However, the use of ACE inhibitors can be associated with angioedema, a rare but life-threatening condition that causes swelling of the face and other body parts. This study will evaluate the effectiveness of the drug HOE-140 at decreasing symptoms of angioedema in people taking ACE inhibitors who develop the condition.

Timeline

Start
2007-09
Primary completion
2011-09
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Icatibant Peptide 30 mg Subcutaneous

Indications